Find If You or a Loved One Qualify
For an Eliquis Lawsuit

The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential claims for individuals who have experienced severe bleeding problems from Eliquis, including:

  •  Internal or Gastrointestinal Bleeding
  • Brain Hemorrhage
  • Hemorrhagic Stroke
  • Wrongful Death

There are no fees or expenses unless a recovery is obtained through an Eliquis bleeding lawsuit.

Call Now 1-800-522-0102
Obtain a Free Case Evaluation

Contact Our Lawyers and Provide Details About Your Eliquis Injury Claim

Saiontz & Kirk, PA, Attorneys & Lawyers, Baltimore, MD
Review an Eliquis Injury Lawsuit
Contact the lawyers at Saiontz & Kirk, P.A. if you or a loved one have suffered severe bleeding problems from Eliquis. Financial compensation may be available as a result of the drug maker's failure to adequately warn.
Saiontz & Kirk, PA, Attorneys & Lawyers, Baltimore, MD

Eliquis Lawsuits for Bleeding Problems

eliquis lawsuit

Eliquis (apixaban) is one of a new generation of anticoagulants designed to reduce the risk of stroke among patients with non-valvular atrial fibrillation. However, the medication was introduced without a safe and effective reversal agent and with inadequate warnings about the potential bleeding risks.

Many users have suffered serious and life-threatening injuries as a result of uncontrollable bleeding on Eliquis, where doctors were unable to reverse the side effects of the medication.

Financial compensation or settlements may be available through an Eliquis lawsuit for individuals who have experienced problems, as a result of the drug maker’s:

  • Failure to Adequately Research the Eliquis Bleeding Side Effects;
  • Failure to Warn About the Risk of Uncontrollable Bleeding on Eliquis;
  • Failure to Identify an Eliquis Reversal Agent Before Introducing the Drug;
  • Failure to Recommend Eliquis Blood Monitoring For Patients;
  • Failure to Issue an Eliquis Recall or Updated Warnings Following Reports of Bleeding Problems;

To find out if you or a loved on have a case, request a free consultation.

Learn More About Eliquis Bleeding Lawsuits

Eliquis Injury Risks

Eliquis (apixaban) belongs to a class of new anticoagulants known as Factor Xa inhibitor, which also includes the medications Pradaxa and Xarelto. It was developed by Pfizer and Bristol-Myers Squibb, and has been aggressively promoted in direct-to-consumer advertisements.

Approved by the FDA in December 2012, Eliquis is prescribed to reduce the risk of blood clots. It is promoted as a superior replacement for Coumadin, sold generically as Warfarin, which has been the leading anticoagulant for decades. However, users may face a substantial risk of suffering severe injury or wrongful death from bleeding problems while using Eliquis, which was not adequately disclosed on the drug label.

Shortly after the medication was introduced, reports of Eliquis bleeding problems began to surface, raising similar concerns to those linked to Xarelto side effects and Pradaxa side effects.

While doctors are able to quickly reverse the effects of warfarin if bleeding develops, there was no approved antidote for Eliquis, Pradaxa or Xarelto at the time these new medications were introduced.

Due to a lack of adequate warnings provided by the drug makers, many individuals have suffered severe bleeding complications, where doctors were unable to stop blood loss. This uncontrollable bleeding may result in:

  • Extended Hospitalization
  • Intensive Care Treatment (ICU)
  • Blood Transfusions
  • Wrongful Death

Recent studies have also raised questions about the claims by the drug makers that Eliquis does not require blood monitoring, as it is possible such recommendations may have helped doctors identify individuals who may be at risk of bleeds on Eliquis.


Eliquis Problems

The study used to approve Eliquis, ARISTOTLE, was published in 2012 in the New England Journal of Medicine.  However, it immediately came under fire by the journal’s former editor, Dr. Arnold Relman, as an example of how corporate backing can lead to skewed study results.

In a Forbes article published in September 2011, Dr. Relman noted that the study compared the safety and efficacy of Eliquis to warfarin. However, he pointed out that what the study authors did not mention in the article outlining the results was that more than a third of the patients were not given an actual therapeutic dose of Warfarin, which could explain why Warfarin appeared to have a higher rate of blood clots and strokes than those given Eliquis.

Others have pointed out that the study’s findings failed to mention at least one patient death. There are also concerns that the researchers, funded by Bristol Myers-Squibb, falsified data and intentionally “lost” records just before an FDA inspection under orders from a company employee.

According to allegations raised in Eliquis lawsuits, there was been no adequate testing of the safety or efficacy of of the drug prior to promoting the medication for use by individuals throughout the United States.

Also Investigating Bleeding Lawsuits For:


Pradaxa (dabigatran) was the first member of this new class of anticoagulants, introduced by Boehringer Ingelheim in October 2010.  Shortly after the medication hit the market, it was linked to a surprising number of severe bleeding problems and wrongful deaths.

Following several years of litigation, millions have been paid by the drug maker in Pradaxa settlements. However, as additional reports of bleeding problems continue to surface, Pradaxa cases continue to be filed by individuals nationwide.

▸ Learn More About Pradaxa Lawsuits


Bayer Healthcare and Janssen Pharmaceuticals face thousands of lawsuits over Xarelto side effects, raising similar allegations to those that will be presented in Eliquis cases.

Xarelto (rivaroxoaban) was introduced in 2011, and became the most widely used drug out of the new class of novel oral anticoagulants. As more people were switched to this new drug, increasing reports of Xarelto bleeding problems surfaced, often resulting in severe injury or wrongful death.

▸ Learn More About Xarelto Lawsuits

No Fees or Expenses Unless You Receive an Eliquis Settlement

As a result of the drug maker’s apparent decision to place their desire for profits before consumers safety, financial compensation may be available through an Eliquis injury settlement.

Saiontz & Kirk, P.A. is a nationally known injury law firm that is focused exclusively on representing individuals, we do not represent corporations or insurance companies. Over the course of more than 40 years, our personal injury lawyers have collected more than $1 billion in compensation for our clients in cases of medical malpractice, automobile accidents, product liability and other personal injury lawsuits.

All Eliquis lawsuits will be handled by our attorneys on a contingency fee basis, which means that there are never any out-of-pocket expenses to hire our law firm and we only receive a fee if compensation is secured for our client.

Protect your family and find out if you or a loved one may be eligible to pursue an Eliquis injury case.  Request a free consultation and claim evaluation.

Steps to Find Out If You Have a Case:

To Find Out If You May Have A Case, Contact Saiontz & Kirk, P.A. By Calling Toll Free at 1-800-522-0102.A Free Consultation and Case Evaluation Can Also Be Obtained By Completing Our On-Line Request Form Below.
During a Free Consultation and Claim Evaluation, Saiontz & Kirk, P.A. Will Review the Circumstances Surrounding Your Case and Help Determine Whether Financial Compensation May Be Available.You Will Have an Opportunity to Speak with a Lawyer and Review Any Questions or Concerns Before Moving Forward With a Case.
After Saiontz & Kirk, P.A. Agrees to Take Your Case, It Remains Your Decision Whether To Hire Our Law Firm.There Are Never Any Out-of-Pocket Costs and We Receive No Attorney Fees or Expenses Unless a Recovery is Obtained.

Obtain a Free Eliquis Lawsuit Evaluation

To request a free consultation and Eliquis case evaluation with the lawyers at Saiontz & Kirk, P.A., complete the form below and provide information about your claim. Our law firm can also be reached toll free at 1-800-522-0102.

During the case evaluation, Saiontz & Kirk, P.A. will review the circumstances surrounding the injury and help determine whether financial compensation or a Eliquis settlement may be available. You will have an opportunity to speak with a lawyer and review any questions or concerns before moving forward with a case.

Provide Complete Contact Information and Details About Your Case

DISCLAIMER: By submitting a request for a free consultation and claim evaluation, you are not retaining an attorney. No attorney-client relationship is formed until a case is accepted by our office and a contingency fee agreement is signed. In some cases, Saiontz & Kirk, P.A. may associate with outside attorneys as lead counsel, at no additional cost to the client. There is no obligation to retain our services.